Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Hodgkin's Lymphoma Refractory/Relapsed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03349281
What this trial is testing

Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL

Who this might be right for
Refractory Acute Lymphoblastic LeukemiaRelapsed Acute Lymphoblastic Leukemia
Julio Barredo, MD 6
Large-scale testing (Phase 3)Ended earlyNCT00363636
What this trial is testing

Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Lymphoma, Non-Hodgkin's
Biogen 340
Early research (Phase 1)Study completedNCT00962507
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
City of Hope Medical Center 11
Testing effectiveness (Phase 2)WithdrawnNCT03212807
What this trial is testing

Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL

Who this might be right for
EBV Related Non-Hodgkin's LymphomaPrimary CNS LymphomaPrimary Testicular Lymphoma
Singapore General Hospital
Testing effectiveness (Phase 2)Study completedNCT05322330
What this trial is testing

Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
The First Affiliated Hospital of Soochow University 20
Very early researchLooking for participantsNCT06446128
What this trial is testing

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

Who this might be right for
Non-Hodgkin Lymphoma, B-cell
Shanghai Cell Therapy Group Co.,Ltd 20
Testing effectiveness (Phase 2)Study completedNCT01538641
What this trial is testing

Phase II Evaluation of Gemcitabine- Rituximab-Oxaliplatin Combination (GROC) in Relapsed Aggressive Lymphomas

Who this might be right for
Refractory Aggressive Non-Hodgkin's LymphomaRelapsing Aggressive Non-Hodgkin's Lymphoma
Auxilio Mutuo Cancer Center 43
Early research (Phase 1)Study completedNCT03263637
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies

Who this might be right for
Relapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more
AstraZeneca 44
Testing effectiveness (Phase 2)Study completedNCT01995669
What this trial is testing

Lenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin Lymphoma

Who this might be right for
Grade 3a Follicular LymphomaRecurrent Follicular LymphomaRecurrent Grade 1 Follicular Lymphoma+7 more
M.D. Anderson Cancer Center 66
Early research (Phase 1)Looking for participantsNCT07451054
What this trial is testing

CD45BE-HSPC + CART-45 Cells

Who this might be right for
B-Cell Non-Hodgkin Lymphoma (NHL)Richter's TransformationT-Cell Non-Hodgkin Lymphoma+1 more
University of Pennsylvania 42
Testing effectiveness (Phase 2)Study completedNCT00179660
What this trial is testing

Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkins Lymphoma
Celgene Corporation 50
Testing effectiveness (Phase 2)Looking for participantsNCT03571568
What this trial is testing

BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL

Who this might be right for
Indolent B-Cell Non-Hodgkin Lymphoma
BioInvent International AB 140
Early research (Phase 1)Active Not RecruitingNCT06334991
What this trial is testing

Study for Participants With Relapsed/Refractory Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma Refractory/ Relapsed
ImmunityBio, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00109967
What this trial is testing

CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent Mantle Cell Lymphoma
National Cancer Institute (NCI) 71
Testing effectiveness (Phase 2)Ended earlyNCT00005950
What this trial is testing

506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma

Who this might be right for
Angioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+7 more
National Cancer Institute (NCI) 111
Early research (Phase 1)Study completedNCT00003082
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Arizona 27
Testing effectiveness (Phase 2)Study completedNCT03458260
What this trial is testing

Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Aggressive Non-Hodgkin Lymphoma
The Lymphoma Academic Research Organisation 74
Early research (Phase 1)Ended earlyNCT00587015
What this trial is testing

A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Lymphoma
MedImmune LLC 50
Testing effectiveness (Phase 2)Study completedNCT05269940
What this trial is testing

Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological Malignancies

Who this might be right for
Non Hodgkin LymphomaPeripheral T Cell LymphomaCLL/SLL
Nanjing Zenshine Pharmaceuticals 40
Early research (Phase 1)Ended earlyNCT06210243
What this trial is testing

C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, B-CellCAR-T
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 2
Next Page